Incremental health care resource use and costs among adult patients with depression and treated for insomnia with zolpidem, trazodone, or benzodiazepines

References

• Friedrich MJ. Depression is the leading cause of disability around the world. Jama. 2017;317(15):1517.
   Web of Science ®Google Scholar
• Nutt D, Wilson S, Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 2008;10(3):329–336.
   PubMedGoogle Scholar
• Stewart R, Besset A, Bebbington P, et al. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep. 2006;29(11):1391–1397.
   PubMed Web of Science ®Google Scholar
• Yates WR, Mitchell J, John Rush A, et al. Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. Prim Care Companion J Clin Psychiatry. 2007;9(1):7–15.
   PubMedGoogle Scholar
• Hamilton M. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry. 1989;154:201–206.
   PubMed Web of Science ®Google Scholar
• Gebara MA, Siripong N, DiNapoli EA, et al. Effect of insomnia treatments on depression: a systematic review and meta-analysis. Depress Anxiety. 2018;35(8):717–731.
   PubMed Web of Science ®Google Scholar
• Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? Jama. 1989;262(11):1479–1484.
   PubMed Web of Science ®Google Scholar
• Li L, Wu C, Gan Y, et al. Insomnia and the risk of depression: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2016;16(1):375.
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Fournier AA, Sisitsky T, et al. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155–162.
   PubMed Web of Science ®Google Scholar
• Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307–349.
   PubMed Web of Science ®Google Scholar
• Overland S, Glozier N, Sivertsen B, et al. A comparison of insomnia and depression as predictors of disability pension: the HUNT study. Sleep. 2008;31(6):875–880.
   PubMed Web of Science ®Google Scholar
• Agargun MY, Cartwright R. REM sleep, dream variables and suicidality in depressed patients. Psychiatry Res. 2003;119(1–2):33–39.
   PubMed Web of Science ®Google Scholar
• Singareddy RK, Balon R. Sleep and suicide in psychiatric patients. Ann Clin Psychiatry. 2001;13(2):93–101.
   PubMedGoogle Scholar
• Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017;14(7–8):24–34.
   PubMedGoogle Scholar
• Roy AN, Smith M. Prevalence and cost of insomnia in a state medicaid fee-for-service population based on diagnostic codes and prescription utilization. Sleep Med. 2010;11(5):462–469.
   PubMed Web of Science ®Google Scholar
• Bayer AJ, Pathy MS, Ankier SI. Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly. Br J Clin Pharmacol. 1983;16(4):371–376.
   PubMed Web of Science ®Google Scholar
• Bronskill SE, Campitelli MA, Iaboni A, et al. Low-dose trazodone, benzodiazepines, and fall-related injuries in nursing homes: a matched-cohort study. J Am Geriatr Soc. 2018;66(10):1963–1971.
   PubMed Web of Science ®Google Scholar
• Atkin T, Comai S, Gobbi G. Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery. Pharmacol Rev. 2018;70(2):197–245.
   PubMed Web of Science ®Google Scholar
• Mokhar A, Tillenburg N, Dirmaier J, et al. Potentially inappropriate use of benzodiazepines and z-drugs in the older population-analysis of associations between long-term use and patient-related factors. PeerJ. 2018;6:e4614.
   PubMed Web of Science ®Google Scholar
• Jones CM, Guy GP Jr, Board A. Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020. Drug Alcohol Depend. 2021;219:108486.
   PubMed Web of Science ®Google Scholar
• Czeisler ME, Lane RI, Petrosky E, et al. Mental health, substance use, and suicidal ideation during the COVID-19 Pandemic – United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049–1057.
   PubMed Web of Science ®Google Scholar
• Consumer Price Index. Measuring Price Change in the CPI: Medical Care. 2020. (Accessed October 29, 2020). https://www.bls.gov/cpi/factsheets/medical-care.htm.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
   PubMed Web of Science ®Google Scholar
• DiBonaventura M, Richard L, Kumar M, et al. The association between insomnia and insomnia treatment side effects on health status, work productivity, and healthcare resource use. PLOS One. 2015;10(10):e0137117.
   PubMed Web of Science ®Google Scholar
• Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep. 2007;30(3):263–273.
   PubMed Web of Science ®Google Scholar
• Pollack M, Seal B, Joish VN, et al. Insomnia-related comorbidities and economic costs among a commercially insured population in the United States. Curr Med Res Opin. 2009;25(8):1901–1911.
   PubMed Web of Science ®Google Scholar
• Wickwire EM, Tom SE, Scharf SM, et al. Untreated insomnia increases all-cause health care utilization and costs among medicare beneficiaries. Sleep. 2019;42(4):zsz007.
   PubMed Web of Science ®Google Scholar
• Wickwire EM, Vadlamani A, Tom SE, et al. Economic aspects of insomnia medication treatment among medicare beneficiaries. Sleep. 2020;43(1):zsz192.
   Web of Science ®Google Scholar
• Asche CV, Joish VN, Camacho F, et al. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder. Curr Med Res Opin. 2010;26(8):1843–1853.
   PubMed Web of Science ®Google Scholar
• Amari D, Juday T, Frech F, et al. Higher health care resource use and costs associated with falls among elderly medicare beneficiaries on commonly used insomnia medications in the United States. J Manag Care Pharm. 2020;26:S46.
   Google Scholar
• Tom SE, Wickwire EM, Park Y, et al. Nonbenzodiazepine sedative hypnotics and risk of fall-related injury. Sleep. 2016;39(5):1009–1014.
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Comandini A, Catena Dell'Osso M, et al. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012;26(12):1033–1049.
   PubMed Web of Science ®Google Scholar
• Wong J, Murray Horwitz M, Bertisch SM, et al. Trends in dispensing of zolpidem and low-dose trazodone among commercially insured adults in the United States, 2011-2018. Jama. 2020;324(21):2211–2213.
   PubMed Web of Science ®Google Scholar
• Schroeck JL, Ford J, Conway EL, et al. Review of safety and efficacy of sleep medicines in older adults. Clin Ther. 2016;38(11):2340–2372.
   PubMed Web of Science ®Google Scholar
• Leger D, Poursain B. An international survey of insomnia: under-recognition and under-treatment of a polysymptomatic condition. Curr Med Res Opin. 2005;21(11):1785–1792.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–133.
   PubMed Web of Science ®Google Scholar
• Mandelkorn U, Genzer S, Choshen-Hillel S, et al. Escalation of sleep disturbances amid the COVID-19 pandemic: a cross-sectional international study. J Clin Sleep Med. 2021;17(1):45–53.
   PubMed Web of Science ®Google Scholar
• Hamel L, Kearney A, Kirzinger A, et al. Health tracking Poll- July. Kaiser Family Foundation. 2020;2020.
   Google Scholar
• Maust DT, Solway E, Clark SJ, et al. Prescription and nonprescription sleep product use among older adults in the United States. Am J Geriatr Psychiatry. 2019;27(1):32–41.
   PubMed Web of Science ®Google Scholar